HIGHLIGHTS
- who: JHEOR and colleagues from the in the Treatment of Overactive Bladder in Spain have published the paper: Clinical and Economic Evaluation of Transdermal Oxybutynin, in the Journal: (JOURNAL)
- what: Background: This study evaluated the clinical outcomes and economic results of transdermal oxybutynin compared to fesoterodine tolterodine solifenacin oxybutynin trospium chloride and mirabegron for overactive bladder syndrome in Spain. Economic evaluation models are studies of secondary sources that, like systematic reviews, have a certain amount of validity, provided that the studies used for this purpose have that internal and external validity.
- how: This . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.